Mass Spectrometry Can Monitor Treatment Response in Multiple Myeloma
Patients converting from mass spectrometry positivity to negativity had excellent progression-free survival, while those converting to positivity progressed early
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.